Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 64 holding rows worth $558,011,000.

Accession
0001493152-17-013235
Filed
2017-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 64 entries on the cover page, a total value of $558,011,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $558,011,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IMMUNOMEDICS INC452907108COM6,737,706$94,193,000thousands by filing date
iShares Russell 2000 ETF464287655SHS465,000$68,904,000thousands by filing dateput
SPDR SER TR78464A870S&P BIOTECH560,000$48,479,000thousands by filing dateput
ASSEMBLY BIOSCIENCES INC045396108COM1,000,000$34,920,000thousands by filing date
VERACYTE INC COM92337F107Stock3,295,111$28,898,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM3,431,809$26,597,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS2,724,283$24,382,000thousands by filing date
IRIDEX CORP462684101COM2,000,000$18,740,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR500,000$18,125,000thousands by filing date
EDGE THERAPEUTICS INC279870109COM1,253,394$13,449,000thousands by filing date
KADMON HLDGS INC48283N106COM3,333,333$11,167,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM1,721,299$10,672,000thousands by filing date
IMMUNOMEDICS INC452907108COM667,500$9,332,000thousands by filing datecall
ZOGENIX INC.98978L204Common Stock250,000$8,763,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR200,000$8,488,000thousands by filing dateput
DBV TECHNOLOGIES S A23306J101ADR192,000$8,148,000thousands by filing date
EVOLENT HEALTH INC CL A30050B101Stock450,000$8,010,000thousands by filing date
Viewra, Inc92672L107COM1,331,983$7,672,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM80,000$6,592,000thousands by filing datecall
ACADIA PHARMACEUTICALS INC004225108COM170,000$6,404,000thousands by filing date
Johnson & Johnson478160104COM45,000$5,850,000thousands by filing dateput
ZOGENIX INC.98978L204Common Stock160,000$5,608,000thousands by filing dateput
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock996,300$5,221,000thousands by filing date
INVITAE CORP46185L103COM528,000$4,947,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR216,255$4,890,000thousands by filing date
CAS MED SYS INC124769209COM5,093,276$4,686,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM300,000$4,524,000thousands by filing date
ISHARES TR464287184CHINA LG-CAP ETF100,000$4,404,000thousands by filing dateput
VIVEVE MED INC92852W204COM NEW827,340$4,335,000thousands by filing date
SEATTLE GENETICS INC812578102COM70,000$3,809,000thousands by filing dateput
NABRIVA THERAPEUTICS PLCG63637105SHS400,000$3,276,000thousands by filing date
TOCAGEN INC888846102COM251,112$3,129,000thousands by filing date
QUOTIENT LTDG73268107SHS569,145$2,806,000thousands by filing date
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK250,000$2,773,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM70,000$2,637,000thousands by filing datecall
LANNETT COMPANY INCORPORATED516012101COM127,500$2,352,000thousands by filing dateput
AMICUS THERAPEUTICS INC03152W109COM151,000$2,277,000thousands by filing datecall
SEATTLE GENETICS INC812578102COM40,000$2,176,000thousands by filing datecall
ROCKWELL MED INC774374102COM250,000$2,140,000thousands by filing dateput
ALEXION PHARMACEUTICALS INC015351109COM15,000$2,104,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock20,000$1,935,000thousands by filing dateput
NIGHTSTAR THERAPEUTICS PLC65413A101ADR100,000$1,920,000thousands by filing date
GOGO INC38046C109COM135,000$1,594,000thousands by filing dateput
EVOLENT HEALTH INC CL A30050B101Stock83,000$1,477,000thousands by filing datecall
AIMMUNE THERAPEUTICS INC.00900T107Common Stock58,525$1,451,000thousands by filing date
COMBIMATRIX CORPORATION20009T147*W EXP 03/18/202564,200$1,411,000thousands by filing date
Accelerate Diagnostics00430H102COM60,000$1,347,000thousands by filing dateput
ALIMERA SCIENCES INC016259103COM974,318$1,315,000thousands by filing date
EVERTEC INC30040P103COM68,800$1,090,000thousands by filing dateput
PORTOLA PHARMACEUTICALS INC COM737010108Stock20,000$1,081,000thousands by filing dateput
RA PHARMACEUTICALS INC74933V108COM71,500$1,044,000thousands by filing date
TELADOC HEALTH INC87918A105COM30,000$995,000thousands by filing dateput
GLAUKOS CORP COM377322102Stock30,000$990,000thousands by filing dateput
AMAG PHARMACEUTICALS INC00163U106COM50,000$923,000thousands by filing dateput
COMBIMATRIX CORPORATION20009T501COM PAR111,912$839,000thousands by filing date
MIMEDX GROUP INC602496101COM70,000$832,000thousands by filing dateput
MANNKIND CORP COM NEW56400P706Stock350,000$760,000thousands by filing dateput
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK40,000$492,000thousands by filing dateput
DBV TECHNOLOGIES S A23306J101ADR9,000$382,000thousands by filing datecall
AXOVANT SCIENCES LTDG0750W104COM20,300$140,000thousands by filing datecall
OTONOMY INC68906L105COM17,500$57,000thousands by filing datecall
ONCOBIOLOGICS INC68235M105COM29,082$40,000thousands by filing date
ONCOBIOLOG-CW17A68235M113EQUITY WRT96,833$12,000thousands by filing date
ONCOBIOLOGICS INC68235M121*W EXP 05/18/20196,833$5,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-17-013235this filing2017-11-14acceptance time not in the bulk data set